A 55-year-old female on methotrexate presents with continuous pain and swelling of bilateral hand joints. What is the best treatment plan for this patient?
Wait, the symptoms are continuous pain and swelling in bilateral hand joints. That's classic for rheumatoid arthritis. But if she's already on methotrexate and not improving, maybe she needs a different DMARD. Alternatively, could it be gout or pseudogout? Those can also affect the joints. But methotrexate doesn't treat gout. Another possibility is osteoarthritis, which is more common in older patients and affects the distal interphalangeal joints. But the question mentions bilateral hand joints, which could be either.
But the key here is that she's on methotrexate. So if her condition isn't improving, maybe she needs a second-line DMARD like TNF-alpha inhibitors. However, the question is about the best treatment plan. Let's consider the options. If the answer is to continue methotrexate with a biologic, that's a common approach in RA. Alternatively, if she's not responding, maybe switching to another DMARD. But without knowing the options, it's hard. Wait, the user didn't provide options A-D. Hmm, maybe the correct answer is to add a TNF inhibitor. But I need to think about possible options.
Wait, the user provided the correct answer as [Letter]. [Answer Text], but the options are missing. So I need to reconstruct the answer based on standard knowledge. The patient is on methotrexate for RA, not responding, so the next step is to add a biologic DMARD like etanercept. So the correct answer would be adding a TNF-alpha inhibitor. The options might include options like adding a biologic, switching to another DMARD, or using NSAIDs. The incorrect options could be things like stopping methotrexate, using corticosteroids, or NSAIDs as first-line.
So in the explanation, the core concept is the management of rheumatoid arthritis with DMARDs. The correct answer is adding a biologic DMARD like etanercept to methotrexate. The wrong options would be things like stopping methotrexate, using NSAIDs alone, or using corticosteroids as first-line. The clinical pearl is that combination therapy with methotrexate and biologics is standard in RA when monotherapy fails.
**Core Concept**
The question tests the management of rheumatoid arthritis (RA) in a patient not responding to methotrexate. Key concepts include the use of disease-modifying antirheumatic drugs (DMARDs) and biologics like TNF-alpha inhibitors as second-line therapy for RA.
**Why the Correct Answer is Right**
Methotrexate is the first-line DMARD for RA, but if it fails, combination therapy with biologics (e.g., etanercept, adalimumab) is indicated. Biologics target cytokines like TNF-alpha, reducing inflammation and joint destruction.